Binyu Luo

Binyu Luo

Auto-generated profile, based on publicly available information

Binyu Luo

National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, Beijing, 100091, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
WWWenting Wang
Wenting Wang
SWSutong Wang
Sutong Wang
YLYiwen Li
Yiwen Li
MZMengmeng Zhu
Mengmeng Zhu
QXQian Xu
Qian Xu
YLYue Liu
Yue Liu

3 August 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
BLBinyu Luo
Binyu Luo
YLYiwen Li
Yiwen Li
MZMengmeng Zhu
Mengmeng Zhu
JCJing Cui
Jing Cui
YLYanfei Liu
Yanfei Liu
YLYue Liu
Yue Liu
Intermittent hypoxia (IH) has a dual nature. On the one hand, chronic IH (CIH) is an important pathologic feature of obstructive sleep apnea (OSA) syndrome (OSAS), and many studies have confirmed that OSA‐related CIH (OSA‐CIH) has atherogenic effects involving complex and interacting mechanisms. Limited preventive and treatment methods are currently available for this condition. On the other hand, non‐OSA‐related IH has beneficial or detrimental effects on the body, depending on the degree, duration, and cyclic cycle of hypoxia. It includes two main states: intermittent hypoxia in a simulated plateau environment and intermittent hypoxia in a normobaric environment. In this paper, we compare the two types of IH and summarizes the pathologic mechanisms and research advances in the treatment of OSA‐CIH‐induced atherosclerosis (AS), to provide evidence for the systematic prevention and treatment of OSAS‐related AS.